Preclinical Science Regarding Cannabinoids as Analgesics: An Overview
Modern pharmacology of cannabinoids began in 1964 with the isolation and partial synthesis of delta-9-tetrahydrocannabinol, the main psychoactive agent in herbal cannabis. Since then, potent antinociceptive and antihyperalgesic effects of cannabinoid agonists in animal models of acute and chronic pa...
Saved in:
Main Author: | ME Lynch |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2005-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2005/169093 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proceedings of the Inaugural Meeting of the Canadian Consortium for the Investigation of Cannabinoids
by: ME Lynch, et al.
Published: (2001-01-01) -
Guidelines for the Use of Cannabinoid Compounds in Chronic Pain
by: AJ Clark, et al.
Published: (2005-01-01) -
Cannabinoids for Pain Management: What is their Role?
by: Alexander J Clark, et al.
Published: (2005-01-01) -
Cannabinoid Hyperemesis
by: Stephen Sullivan
Published: (2010-01-01) -
The Cannabinoids: An Overview. Therapeutic Implications in Vomiting and Nausea after Cancer Chemotherapy, in Appetite Promotion, in Multiple Sclerosis and in Neuroprotection
by: R Mechoulam, et al.
Published: (2001-01-01)